BRO vs IMA · P/E 30, rev $4.80B vs rev $9.2M
Brown & Brown Inc (BRO) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. IMA currently screens at market cap $64.7M.
Not investment advice. Open the BRO and IMA stock pages for the full models.
Not investment advice.